click below
click below
Normal Size Small Size show me how
Seminar
Oncology
| Question | Answer |
|---|---|
| Alkylating Agents | Inhibit DNA and protein synthesis resulting in cell death |
| Cyclophosphamide | Hemorrhagic Cystitis Only with HIGH doses administer Mesna |
| Ifosfamide | Hemorrhagic Cystitis Always administer with Mesna |
| Busulfan | Pulmonary Toxicity Neurotoxicity: Seizures |
| Cyclophosphamide | Alkylating Agent |
| Ifosfamide | Alkylating Agent |
| Busulfan | Alkylating Agent |
| Carmustine | Pulmonary Toxicity Neurotoxicity: Seizures |
| Carmustine | Alylating Agent |
| Platinum Based Compounds | Cross link DNA interfering with DNA synthesis and cell replication resulting in cell death. |
| Cisplatin | Platinum Based Compound |
| Cisplatin | Hypersensitivity Reactions Nephrotoxicity (Amifostene)- Limit to <100 mg/m2 per cycle Ototoxicity Peripheral Neuropathy |
| Oxaliplatin | Platinum Based Compound |
| Oxaliplatin | Hypersensitivity Reactions Nephrotoxicity Ototoxicity Peripheral Neuropathy- EXACERBATED BY COLD |
| Carboplatin | Hypersensitivity Reactions Nephrotoxicity Ototoxicity Peripheral Neuropathy |
| Anthracyclines | Intercalation into DNA, Inhibit Topoisomerase II and create oxygen free radicals that damage cells. |
| Doxorubicin | Anthracycline |
| Mitoxanthrone | Anthracycline |
| Doxorubicin | Cardiotoxicity- GIVE Dexrazoxane, Total Lifetime Dose 450-550 mg/m2 Red Discoloration |
| Mitoxanthrone | Blue Discoloration |
| Carboplatin | Platinum Based Compound |
| Topoisomerase I Inhibitors | Inhibit the coiling and uncoiling of double stranded DNA in the S phase preventing religation |
| Irinotecan | Topoisomerase I Inhibitor |
| Irinotecan | Acute Diarrhea Cholinergic Symptoms |
| Irinotecan | Topoisomerase I Inhibitor |
| Irinotecan Acute Diarrhea (< 24 hours) | Atropine |
| Irinotecan Delayed Diarrhea (> 24 hours) | Loperamide |
| Topoisomerase II Inhibitors | Inhibit the coiling and uncoiling of double stranded DNA in the G2 phase |
| Etoposide | Topoisomerase II Inhibitor |
| Vinca Alkaloids | Inhibit microtubule formation during the M phase of cell cycle |
| Vincristine | Vinca Alkaloid |
| Vinblastine | Vinca Alkaloid |
| Vincristine | Peripheral Neuropathy- Limit doses to 2 mg Autonomic Neuropathy (Constipation) DO NOT GIVE INTRATHECALLY DEATH |
| Vinblastine | Peripheral Neuropathy Autonomic Neuropathy (Constipation) DO NOT GIVE INTRATHECALLY DEATH |
| Taxanes | Inhibit depolymerization of tubulin during the M phase of the cell cycle |
| Taxanes | Use a 0.22 micron filter and non-PVC bag and tubing |
| Paclitaxel | Peripheral Neuropathy Hypersensitivity Reaction- Premedicate |
| Doceltaxel | Peripheral Neuropathy Hypersensitivity Reaction- Premedicate SEVERE FLUID RETENTION |
| Paclitaxel | Taxane |
| Doceltaxel | Taxane |
| Pyrimidine Analog Antagonists | Inhibit Pyrimidine DNA synthesis during the S phase |
| 5-FU | Pyrimidine Analog Antagonists |
| Capecitabine | Pyrimidine Analog Antagonists |
| 5-FU | HFS Diarrhea Mucositis DPD Deficiency- Increase Toxicity INCREASE INR |
| 5-FU and Capecitabine Antidote | Uridine Triacetate |
| Folate Antagonists | Interfere with the enzymes involved in the folic acid cycle, blocking purine and pyrimidine synthesis in the S phase |
| Methotrexate | Folate Antagonists |
| Methotrexate | Nephrotoxicity HIGH DOSES GI Toxicity |
| Methotrexate Rescue MTX > 500 mg/m2 | Leucorvin |
| Antidote MTX Overdose | Glucarpidase |